The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3
Por um escritor misterioso
Descrição
IMR Press is a leading publisher of open access peer-reviewed biomedical and life sciences journals. We aim to facilitate the dissemination of high-quality research in the area of biomedical science. With a long tradition and wide readership, IMR Press is dedicated to making positive contributions to academics, corporate libraries as well as to readers and authors. All the editors in IMR Press will provide the best service for researchers, allowing them to have a easy and smooth publication experience and helping maximize the impact and visibility of their research.
![The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3](https://d3i71xaburhd42.cloudfront.net/5897cd23e9216feb9433202984fa63e00e43a83d/2-Table1-1.png)
PDF] An Update on the Pathophysiology and Treatment of Cardiorenal
![The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3](https://www.mdpi.com/ijms/ijms-24-05089/article_deploy/html/images/ijms-24-05089-g002.png)
IJMS, Free Full-Text
![The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3](https://www.ahajournals.org/cms/asset/b0520ffa-cbdd-4664-a74d-95ee86274e07/e840fig03.gif)
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis
![The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3](https://www.frontiersin.org/files/Articles/889553/fcvm-09-889553-HTML/image_m/fcvm-09-889553-g001.jpg)
Frontiers Toward Human Models of Cardiorenal Syndrome in vitro
![The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3](https://www.kidney-international.org/cms/asset/66a62b31-d311-4f06-87c5-a23088581f86/fx1.jpg)
Wnt/β-catenin signaling mediates both heart and kidney injury in
![The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3](https://article.imrpress.com/journal/RCM/24/1/10.31083/j.rcm2401008/2153-8174-24-1-008/fig2.jpg)
Progress and Challenges of Understanding Cardiorenal Syndrome Type 3
![The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//08702551/0000003500000011/v1_201610280519/S0870255116301895/v1_201610280519/en/main.assets/gr3.jpeg?xkr=ue/ImdikoIMrsJoerZ+w94UphxYc+GPca8Z7OggvdfJQF4SIqTc4zp8SrbcUWBiKPg+dJZ4Ok3eI2oWItAK4c6qvgsUMOpNoBToF4WrLknnJvw1KMP/xPFSm2A3yjVH1idP2oLna0jYo6LuTkVeHBv+/ovD6t8/mj1vMoKtIfABw2l90JmEHBBp3MSYDEQE7Uwa+4TXtvm6RW2C3dci222MRdsGVNy8Yx7ngOmVPMBl4YUjWnAJw8ObZWphvqw9I+Ymd+2RbnQUyZQhMdcR2JRA2zatjOSBTJPQEUVYmf3c=)
Type 4 cardiorenal syndrome Revista Portuguesa de Cardiologia
![The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3](https://www.frontiersin.org/files/Articles/1125693/fendo-14-1125693-HTML/image_m/fendo-14-1125693-g001.jpg)
Frontiers Cardiovascular-renal protective effect and molecular
![The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3](https://d3i71xaburhd42.cloudfront.net/012e769f4612d3025c9175719e4f377e77f40dea/4-Figure1-1.png)
PDF] Fibrosis, the Bad Actor in Cardiorenal Syndromes: Mechanisms
![The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3](https://www.ahajournals.org/cms/asset/ce210a7d-442d-49d1-a06f-248c16252405/929fig02.gif)
Cardiorenal Syndrome Revisited
de
por adulto (o preço varia de acordo com o tamanho do grupo)